Dopamine hypotheses of several psychiatric disorders are based upon the clinical benefits
of drugs affecting dopamine transporter or receptors, and have prompted intensive candidate …

Major depressive disorder of the mother affects 6 to 17% of pregnancies worldwide and can
lead to negative outcomes, such as preterm delivery and later mental health problems of the …

About 15% of one-year-old infants in non-clinical, low-risk and up to 80% in high-risk (eg
maltreated) populations show extensive disorganized attachment behavior 1, 2 in the Strange …

The gene for the glucocorticoid receptor regulator FK506 binding protein 5 (FKBP5) plays a
role for risk, response to treatment, and changes in brain areas in major depressive disorder (…

Disorganized attachment is an early predictor of the development of psychopathology in
childhood and adolescence. Lyons-Ruth, Bronfman, and Parsons (1999) developed the …

Methylphenidate is the most frequently prescribed drug in the treatment of attention deficit
hyperactivity disorder (ADHD) but it is not effective in every case. Therefore, identifying genetic …

Attachment theorists have suggested the significance of early secure attachment for later
mental health, and indeed, empirical studies seem to support this proposition [for a review, see …

The P2RX7 gene (coding for P2X7 purinergic receptor) has been suggested as a novel
candidate gene for major depressive disorder (MDD) and bipolar disorder (BPD). The proposed …

Background In the development of borderline personality disorder (BPD) both genetic and
environmental factors have important roles. The characteristic affective disturbance and …

Methylphenidate (MPH) is the most frequently prescribed drug in the treatment of attention
deficit hyperactivity disorder (ADHD). Several pharmacogenetic studies suggested that …